Adalat

A Comprehensive Review

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology
Cover of the book Adalat by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642854989
Publisher: Springer Berlin Heidelberg Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783642854989
Publisher: Springer Berlin Heidelberg
Publication: December 6, 2012
Imprint: Springer
Language: English

As little as 30 years ago, cardiovascular research at Bayer was just a small sideline with in an environment dominated by chemotherapy research, and only 15 years ago, Bayer's pharmaceutical business was confined to European and Latin Ameri­ can countries, with sales in cardiovascular pharmaceuticals close to zero. It goes without saying that Adalat has changed the company as a whole in its research, development, and marketing, both in Germany and, most importantly, world­ wide. In research and development, Adalat has led the way in to new areas such as hypertension, acute neurology, dementia, atherosclerosis, and heart failure. In pharmacology, Adalat was present at the dawning of the second phar­ macological revolution, which started out from whole animal models and progres­ sed, via in vitro screening and pharmacological research on the DHP receptor, down to the molecular level with the cloning of calcium-channel proteins. Having followed the Adalat story closely in its early years as a bench scientist, let me take this opportunity to thank the inventors, the scientists, and the investigators who have helped to tap the broad potential of calcium-channel blockade with dihyd­ ropyridines in general and Adalat in particular. But, success should not obscure our vision. There is no reason for us to rest on our laurels: it will take true innovations in cardiovascular research to top the gold standard set by Adalat. Let us take up the challenge.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

As little as 30 years ago, cardiovascular research at Bayer was just a small sideline with in an environment dominated by chemotherapy research, and only 15 years ago, Bayer's pharmaceutical business was confined to European and Latin Ameri­ can countries, with sales in cardiovascular pharmaceuticals close to zero. It goes without saying that Adalat has changed the company as a whole in its research, development, and marketing, both in Germany and, most importantly, world­ wide. In research and development, Adalat has led the way in to new areas such as hypertension, acute neurology, dementia, atherosclerosis, and heart failure. In pharmacology, Adalat was present at the dawning of the second phar­ macological revolution, which started out from whole animal models and progres­ sed, via in vitro screening and pharmacological research on the DHP receptor, down to the molecular level with the cloning of calcium-channel proteins. Having followed the Adalat story closely in its early years as a bench scientist, let me take this opportunity to thank the inventors, the scientists, and the investigators who have helped to tap the broad potential of calcium-channel blockade with dihyd­ ropyridines in general and Adalat in particular. But, success should not obscure our vision. There is no reason for us to rest on our laurels: it will take true innovations in cardiovascular research to top the gold standard set by Adalat. Let us take up the challenge.

More books from Springer Berlin Heidelberg

Cover of the book Pahl/Beitz Konstruktionslehre by
Cover of the book Early Development of the Shoulder Girdle and Sternum in Marsupials (Mammalia: Metatheria) by
Cover of the book Das C++ Kompendium by
Cover of the book JIMD Reports, Volume 32 by
Cover of the book Argumenta Papiniani by
Cover of the book Klüger irren - Denkfallen vermeiden mit System by
Cover of the book The Right(s) to Water by
Cover of the book Meshfree Methods for Partial Differential Equations VI by
Cover of the book Supportive Care in Cancer Patients by
Cover of the book Ecology and Evolution of the Freshwater Mussels Unionoida by
Cover of the book The Reality of M&A Governance by
Cover of the book Grundlagen der Technischen Dokumentation by
Cover of the book Recent Developments in Vector Optimization by
Cover of the book Method of Dimensionality Reduction in Contact Mechanics and Friction by
Cover of the book Aufbruch in die neue Triade China – Indien – Russland by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy